BioAegis Therapeutics Revenue and Competitors

North Brunswick, NJ USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioAegis Therapeutics's estimated annual revenue is currently $2M per year.(i)
  • BioAegis Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • BioAegis Therapeutics has 13 Employees.(i)
  • BioAegis Therapeutics grew their employee count by 8% last year.

BioAegis Therapeutics's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
COOReveal Email/Phone
3
ScientistReveal Email/Phone
4
ScientistReveal Email/Phone
5
Technology and Communications SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.5M55-21%N/AN/A
#2
$0.2M10%N/AN/A
#3
$8.5M55-29%N/AN/A
#4
$108.5M5002%N/AN/A
#5
$0.8M50%N/AN/A
#6
$0.6M40%N/AN/A
#7
$14.7M68-23%$206.4MN/A
#8
$492.2M1503-15%$568MN/A
#9
$1.1M7-42%N/AN/A
#10
$4.5M290%N/AN/A
Add Company

What Is BioAegis Therapeutics?

Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body's natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M150%N/A
#2
$1.7M16-6%N/A
#3
$2.4M17N/AN/A
#4
$1.5M17-6%N/A
#5
$1.5M176%N/A